Acalabrutinib Added To Rituximab, Bendamustine (ABR) in Newly Diagnosed High Risk Mantle Cell Lymphoma: an Early Indian Experience
| Title: | Acalabrutinib Added To Rituximab, Bendamustine (ABR) in Newly Diagnosed High Risk Mantle Cell Lymphoma: an Early Indian Experience |
|---|---|
| Authors: | Panda, TribikramAff1; Pillai, Reshmi HarikumarAff1; Tikare, NakulAff1; Tripathi, SwapnilAff1; Panda, DevasisAff1; Halder, RohanAff1; Sheth, Vipul SharadAff1; Tejwani, NarenderAff1; Bhurani, DineshAff1; Agrawal, NarendraAff1, IDs12288025022578_cor1 |
| Source: | Indian Journal of Hematology and Blood Transfusion. :1-4 |
| Database: | Springer Nature Journals |